Skip to main content
Figure 2 | BMC Biotechnology

Figure 2

From: Intranasal vaccination with messenger RNA as a new approach in gene therapy: Use against tuberculosis

Figure 2

Assessment of the amount of professional antigen-presenting cells capable of capturing mRNA-Hsp65 labeled with Alexa488. Five BALB/c mice per group were immunized by intranasal route with one dose of 10 μg of Alexa488 labeled mRNA-Hsp65. The control group received Ringer's solution. The kinetics of the capture was made in different times (indicated in the legend) and the cellular phenotype detected by flow cytometry. Data represent the mean positive cell counts ± SD of five mice per group of one of three independent experiments

Back to article page

BMC Biotechnology

ISSN: 1472-6750

Contact us